Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$50.0M
total disclosed, rounds participated
Stages
—
About
Global Emerging Markets (GEM) is a $3.4 billion alternative investment group founded in 1991. It manages a diverse set of investment vehicles focused on emerging markets across the world, with a diversified portfolio of asset classes spanning the global private investing spectrum. GEM's investment vehicles provide exposure to small-mid cap management buyouts, private investments in public equities (PIPEs), and select venture investments. The firm has offices in New York, Paris, and Nassau, Bahamas.
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Global Emerging Markets Group (GEM)'s primary investment focus?
- Global Emerging Markets Group (GEM) primarily focuses on the Health Tech & Life Sciences sector, with its sole disclosed portfolio company, POCARED Diagnostics, operating in this area.
- When did Global Emerging Markets Group (GEM) make its most recent disclosed investment?
- Global Emerging Markets Group (GEM)'s most recent disclosed investment occurred in July 2021.
- Can you name a notable company in Global Emerging Markets Group (GEM)'s portfolio?
- A notable company in Global Emerging Markets Group (GEM)'s portfolio is POCARED Diagnostics, which develops automated, reagent-free microorganism detection technology.
- What is the typical investment range for Global Emerging Markets Group (GEM)?
- Global Emerging Markets Group (GEM) typically invests in the range of $50M.
- What is the total amount raised by POCARED Diagnostics, a Global Emerging Markets Group (GEM) portfolio company?
- POCARED Diagnostics, a portfolio company of Global Emerging Markets Group (GEM), has raised $103.38M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Global Emerging Markets |
|---|---|
| Founded | 1991 |